免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

FDA 510(k)

cCeLL - 在体

K号: K233391 · 2024-08-21

决定日期2024-08-21
产品代码GWG
咨询委员会NE 请注意,您提供的文本“NE”不足以进行翻译,因为它不是一个完整的句子或描述。请提供完整的医疗设备监管文本,以便我能够进行准确的翻译。
决定实质等同

器械摘要

cCeLL - In vivo is the device name listed in this FDA 510(k) record. The listed applicant is VPIX Medical, Inc.. It received FDA 510(k) clearance on 2024-08-21 under 510(k) number K233391. The device is classified under product code GWG. It was reviewed by the NE advisory panel. FDA Decision: Substantially Equivalent.

常见问题

What is the cCeLL - In vivo?

cCeLL - In vivo is a medical device that received FDA 510(k) clearance on 2024-08-21. The listed applicant is VPIX Medical, Inc.. The 510(k) number is K233391.

When did cCeLL - In vivo receive FDA 510(k) clearance?

cCeLL - In vivo received FDA 510(k) clearance on 2024-08-21, under 510(k) number K233391.

Who is the listed applicant for cCeLL - In vivo?

The FDA 510(k) record lists VPIX Medical, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for cCeLL - In vivo?

The FDA product code for cCeLL - In vivo is GWG.

相关临床试验

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

列明VPIX Medical, Inc.为申报人的其他记录

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

相关器械(代码:GWG)

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息,请务必参考官方记录。

↑